Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Judkins
Matthew Judkins, Buckinghamshire GB
| Patent application number | Description | Published |
|---|---|---|
| 20120058677 | Electrical Plug - This invention relates to an electrical plug ( | 03-08-2012 |
Paul Judkins, Toronto CA
| Patent application number | Description | Published |
|---|---|---|
| 20090116732 | METHODS AND SYSTEMS FOR CONVERTING 2D MOTION PICTURES FOR STEREOSCOPIC 3D EXHIBITION - The present invention discloses methods of digitally converting 2D motion pictures or any other 2D image sequences to stereoscopic 3D image data for 3D exhibition. In one embodiment, various types of image data cues can be collected from 2D source images by various methods and then used for producing two distinct stereoscopic 3D views. Embodiments of the disclosed methods can be implemented within a highly efficient system comprising both software and computing hardware. The architectural model of some embodiments of the system is equally applicable to a wide range of conversion, re-mastering and visual enhancement applications for motion pictures and other image sequences, including converting a 2D motion picture or a 2D image sequence to 3D, re-mastering a motion picture or a video sequence to a different frame rate, enhancing the quality of a motion picture or other image sequences, or other conversions that facilitate further improvement in visual image quality within a projector to produce the enhanced images. | 05-07-2009 |
| 20100231593 | METHODS AND SYSTEMS FOR DIGITALLY RE-MASTERING OF 2D AND 3D MOTION PICTURES FOR EXHIBITION WITH ENHANCED VISUAL QUALITY - The present invention relates to methods and systems for the exhibition of a motion picture with enhanced perceived resolution and visual quality. The enhancement of perceived resolution is achieved both spatially and temporally. Spatial resolution enhancement creates image details using both temporal-based methods and learning-based methods. Temporal resolution enhancement creates synthesized new image frames that enable a motion picture to be displayed at a higher frame rate. The digitally enhanced motion picture is to be exhibited using a projection system or a display device that supports a higher frame rate and/or a higher display resolution than what is required for the original motion picture. | 09-16-2010 |
Robert Judkins, Molndal SE
| Patent application number | Description | Published |
|---|---|---|
| 20080255122 | Derivatives of Isothiazol-3(2H)-One 1,1-Dioxides as Liver X Receptor Modulators - The present invention relates to certain novel compounds of the formula (I) to processes for preparing such compounds, to their the utility in modulation of nuclear hormone receptors Liver X Receptor (LXR) α (NR1H3) and/or β (NR1H2) and in treating and/or preventing clinical conditions including cardiovascular diseases such as atherosclerosis; inflammatory diseases, Alzheimer's disease, lipid disorders (dyslipidemias) whether or not associated with insulin resistance, type 2 diabetes and other manifestations of the metabolic syndrome, to methods for their therapeutic use and to pharmaceutical compositions containing them. | 10-16-2008 |
| 20090005353 | Non-Anilinic Derivatives of Isothiazol-3(2H)-one 1,1-Dioxides as Liver X Receptor Modulators - The present invention relates to certain novel compounds of the formula (I) | 01-01-2009 |
| 20100016321 | DERIVATIVES OF ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDES AS LIVER X RECEPTOR MODULATOR - The present invention relates to certain novel compounds of the formula (I) to processes for preparing such compounds, to their utility in modulation of nuclear hormone receptors Liver X Receptor (LXR) α (NR1H3) and/or β (NR1H2) and in treating and/or preventing clinical conditions including cardiovascular diseases such as atherosclerosis; inflammatory diseases, Alzheimer's disease, lipid disorders (dyslipidemias) whether or not associated with insulin resistance, type 2 diabetes and other manifestations of the metabolic syndrome, to methods for their therapeutic use and to pharmaceutical compositions containing them. | 01-21-2010 |
| 20100227847 | Non-Anilinic Derivatives Of Isothiazol-3(2H)-one 1,1-Dioxides As Liver X Receptor Modulators - The present invention relates to certain novel compounds of the formula (I) to processes for preparing such compounds, to their the utility in modulation of nuclear hormone receptors Liver X Receptor (LXR) α (NR1H3) and/or β (NR1H2) and in treating and/or preventing clinical conditions including cardiovascular diseases such as atherosclerosis; inflammatory diseases, Alzheimer's disease, lipid disorders (dyslipidemias) whether or not associated with insulin resistance, type 2 diabetes and other manifestations of the metabolic syndrome, to methods for their therapeutic use and to pharmaceutical compositions containing them. | 09-09-2010 |
Robert Andrew Judkins, Molndal SE
| Patent application number | Description | Published |
|---|---|---|
| 20100280000 | THERAPEUTIC AGENTS 713 - Disclosed herein are compounds of formula I | 11-04-2010 |
| 20120010189 | (3-(4-(AMINOMETHYL)PHENOXY OR PHENYLTHIO)AZETIDIN-1-YL)(5-PHENYL-1,3,4-OXADIAZOL-2-YL)METHANONE COMPOUNDS - Disclosed herein are azetidinyl compounds of formula I, | 01-12-2012 |